GL1X · GenesisL1 explorer

MolNFT v1 · #161430 · protein + DNA

DNA binding domain of lux arrythmo in complex with DNA

6QEC · DNA (5'- D(*AP*TP*TP*CP*GP*AP*AP*TP*AP*T*TP*AP*TP*AP*TP*TP*C…: “DNA binding domain of lux arrythmo in complex with DNA”. X-ray diffraction, 2 pockets (best druggability 0.35). MolNFT v1 #161430 on GenesisL1: 3D structure, binding…

PDB
6QEC
Type
protein + DNA
Length
85 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA (5'- D(*AP*TP*TP*CP*GP*AP*AP*TP*AP*T*TP*AP*TP*AP*TP*TP*CP*GP*AP*A)-3'); Transcription…
UniProt
Q9SNB4
Pockets
2 · best druggability 0.35

Structure

x-ray diffraction · 3 distinct chains · 65% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
UDNA (5'- D(*AP*TP*TP*CP*GP*AP*AP*TP*AP*T*TP*AP*TP*AP*TP*TP*CP*GP*AP*A)-3')dna10——
BDNA (5'- D(*AP*TP*TP*CP*GP*AP*AP*TP*AP*T*TP*AP*TP*AP*TP*TP*CP*GP*AP*A)-3')dna10——
ATranscription factor luxprotein6565% helix, 0% strandQ9SNB4

Ligands and binding sites

  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11110.350.7316empty
2500.300.7610empty

Interfaces

3 interfaces between chains.

  • B–A · 417 Ų buried · 7 hydrogen bonds · protein-nucleic
  • U–B · 402 Ų buried · 28 hydrogen bonds · nucleic-nucleic
  • U–A · 367 Ų buried · 8 hydrogen bonds · protein-nucleic

Compared structures

  • 6QEC · DNA binding domain of LUX ARRYTHMO in complex with DNA · the same entry in another collection · chain U against U, TM-score 1.00
  • Q9SNB4 · AlphaFold monomer V2.0 prediction for transcription factor lux (Q9SNB4) · a predicted model of the same protein · chain A against A, TM-score 0.81

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.